Perfusion Parameters and Outcome During a Standardized Deresuscitation Strategy with Net Ultrafiltration: a Retrospective Cohort Study.
DeepCART
1 other identifier
observational
120
1 country
1
Brief Summary
Hemodynamic tolerance of fluid removal during deresuscitation is a cornerstone of the impact on outcome of such a strategy. However, how to define and to predict hemodynamic tolerance to fluid removal remains controversial. The investigators routinely use a standardized deresuscitation protocol in patients with fluid overload and continuous renal replacement therapy combined with monitoring of clinical and biological perfusion parameters. The aim of the study was to describe perfusion during deresuscitation, and to determine whether it is associated with major adverse kidney events at day 30.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 21, 2025
CompletedFirst Posted
Study publicly available on registry
March 28, 2025
CompletedMarch 28, 2025
March 1, 2025
2 months
March 21, 2025
March 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
MAKE 30
Major adverse kidney event at day 30, defined as follows: * Death OR * No weaning of renal replacement therapy OR * Serum creatinine \> 2 times baseline serum creatinine
A day 30 after the initiation of the deresuscitation strategy
Study Arms (1)
Standardized deresuscitation strategy
Eligible patients without hypoperfusion benefited from: 1) a restrictive approach of intakes combining hypercaloric enteral or per os feeding with hydric restriction as much as possible and no fluid of maintenance, and 2) a systematic UFnet of 2 mL/kg/h until reaching dry weight and a systematic monitoring every 6 h of: peripheral perfusion by capillary refilling time and mottling score, arterial lactate level, and central venous oxygen saturation.
Interventions
Arterial lactate, pCO2 gap, SvO2, capillary refill time and mottling score anomalies will be described during the first 5 days of the deresuscitation strategy.
Eligibility Criteria
adults' patients with fluid overload and continuous renal replacement therapy in intensive care unit
You may qualify if:
- Age ≥ 18 years old
- Acute kidney injury requiring continuous renal replacement therapy
- Standardized deresuscitation following a routine care protocol
You may not qualify if:
- Chronic hemodialysis
- Advanced directives to withhold or withdraw life-sustaining treatment,
- Patient's opposition to the use of his/her personal health data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Louis Pradel Hospital
France, Bron, 69500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2025
First Posted
March 28, 2025
Study Start
January 1, 2024
Primary Completion
March 1, 2024
Study Completion
April 1, 2024
Last Updated
March 28, 2025
Record last verified: 2025-03